tirzepatide dose for diabetes How should Mounjaro® (tirzepatide) doses be increased in adults? Tirzepatide (Mounjaro) for the Treatment

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

The gastrointestinal side effects of GLP-1 drugs are mediated by the brain, not the gut

GLP-1 Medications: Rethinking My Stance + How to Support Yourself While Using Them Ill admit it: I was extremely biased against GLP-1 medications when I first heard about them

Thats why were excited to introduce Low-Dose Naltrexone (LDN)a once- daily pill that offers remarkable benefits for a wide range of conditions.What is LDN?Low-Dose Naltrexone (LDN) works by temporarily blocking opioid receptors in the brain, triggering a rebound effectthat leads to increased endorphin productio